Development of PDE2 inhibitors for treatment of anxiety/depression in autism/schizophrenia
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43MH108209
- Recipient
-
Intra-Cellular Therapies, Inc. UEI VA5JXLCJHDK7
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $348,094
Award facts
- Assistance listing
- 93.242 Mental Health Research Grants
- Completion date
- Originally
- Place of performance
- New York, NY 10016, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $348,094 |
Quick answers
Who received award R43MH108209?
R43MH108209 was awarded to Intra-Cellular Therapies, Inc. by National Institutes of Health (Department of Health and Human Services) on June 1, 2016.
How much is award R43MH108209 worth?
$348,094 has been obligated on R43MH108209.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award